To achieve a more sustainable cost structure, the company has conducted a thorough review of its operations. In 2026, the board of directors decided to discontinue operations in Germany in order to fully focus on the Nordic core markets.
This strategic shift has already begun to yield results. In 2025, the company reached EBITDA break-even for several individual months in the Nordic region for the first time. The stated goal is now for the Nordic region to deliver profit on a full-year basis by 2028.
Sofie Zettergren Appointed Permanent CEO
Towards the end of 2025, Peter Beckius stepped down from his role as CEO and was succeeded by then CFO Sofie Zettergren as acting CEO. After just over six months in the position, the board of directors has now appointed her as the permanent CEO of the company.
Matsmart has a strong position in the market, an important social mission and a business model that creates value for both consumers and suppliers. We have taken important steps to strengthen our business and create a stable foundation for the future. Now I look forward to continuing to develop the offering, create even greater customer value and build on the positive development we are seeing in our Nordic markets, says Sofie Zettergren.
Gustaf Brandberg, who assumed the position of new chairman of the board in early 2026, emphasizes the board's confidence in Zettergren:
I am impressed by how decisively Sofie has implemented the strategic change by successfully discontinuing operations in Germany and focusing the company on the Nordics, where Matsmart has a strong market position, a profitable business model and good growth. The board is convinced that she is the right person to lead Matsmart in the next phase and capitalize on the potential we see in the company.
New Capital Secured
As part of strengthening the balance sheet and financing the continued path to profitability, Matsmart closed a financing round in early May 2026, where the company was added approximately 100 million SEK from existing owners. The capital injection, together with a significantly lower cost base, is expected to create the stable foundation required to grow with discipline and control going forward.